NASDAQ:UTRS

Minerva Surgical Stock Insider Trading

Healthcare > Medical - Healthcare Information Services

Buy UTRS

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Minerva Surgical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 56.58M and sold 126.82M UTRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	56.58M shares
● Sell	126.82M shares
73% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	455 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	464 Value: $0
Oct 26, 2021 Buy	Common Stock C-Conversion	Jaffe Ross A Md Director	Director	10 473 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	72 374 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	68 634 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	69 613 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	69 613 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	68 634 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	72 374 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	73 816 Value: $0
Oct 26, 2021 Buy	Common Stock C-Conversion	Jaffe Ross A Md Director	Director	1 663 227 Value: $0
Oct 26, 2021 Sell	Subordinated Secured Convertible Promissory Note C-Conversion	Jaffe Ross A Md Director	Director	279 942 Value: $3.17M
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	24 760 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	34 986 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	35 009 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	35 009 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	34 986 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	24 760 Value: $0
Oct 26, 2021 Buy	Common Stock C-Conversion	Jaffe Ross A Md Director	Director	94 755 Value: $0
Oct 26, 2021 Sell	Subordinated Secured Convertible Promissory Note C-Conversion	Jaffe Ross A Md Director	Director	5 257 Value: $59.4K
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	464 Value: $0
Oct 26, 2021 Sell	Series C Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	5 536 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	455 Value: $0
Oct 26, 2021 Sell	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	432 Value: $0
Oct 26, 2021 Buy	Series D Preferred Stock C-Conversion	Jaffe Ross A Md Director	Director	438 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MINERVA SURGICAL, INC.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bl...

Read Full Profile Here